Alliance Pharma (LON:APH) Cut to Hold at Berenberg Bank

Alliance Pharma (LON:APHGet Free Report) was downgraded by stock analysts at Berenberg Bank to a “hold” rating in a report issued on Wednesday, Marketbeat reports. They presently have a GBX 6,250 ($77.62) target price on the stock, down from their prior target price of GBX 7,000 ($86.93).

Alliance Pharma Stock Performance

Shares of APH stock opened at GBX 61.20 ($0.76) on Wednesday. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The firm has a 50-day moving average of GBX 50.26 and a 200-day moving average of GBX 44.25. Alliance Pharma has a one year low of GBX 24.55 ($0.30) and a one year high of GBX 61.60 ($0.77). The company has a market cap of £330.83 million, a P/E ratio of -1,020.00, a P/E/G ratio of 1.04 and a beta of 0.67.

Alliance Pharma Company Profile

(Get Free Report)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.

Recommended Stories

Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.